Evidence map›Paper›PMID 39957801›Full record

ArticleFrontiers in aging neuroscience2025

Individualized diagnosis of Parkinson's disease based on multivariate magnetic resonance imaging radiomics and clinical indexes.

Qianqian Ye, Chenhui Lin, Fangyi Xiao, Tao Jiang, Jialong Hou, Yi Zheng, Jiaxue Xu, Jiani Huang, Keke Chen, Jinlai Cai and 3 more

Abstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Qianqian Ye *Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Chenhui Lin *Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Fangyi XiaoDepartment of Cardiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Tao JiangDepartment of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Jialong HouDepartment of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Yi ZhengDepartment of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Jiaxue XuDepartment of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Jiani HuangDepartment of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Keke ChenDepartment of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Jinlai CaiDepartment of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Jingjing QianDepartment of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Weiwei QuanDepartment of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Yanyan ChenDepartment of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To explore MRI-based radiomics models, integrating clinical characteristics, for differential diagnosis of Parkinson's disease (PD) to evaluate their diagnostic performance. Methods: A total of 256 participants [153 PD, 103 healthy controls (HCs)] from the First Affiliated Hospital of Wenzhou Medical Hospital, were enrolled as the training set, and 120 subjects (74 PD, 46 HCs) from the PPMI dataset served as the test set. Radiomics features were extracted from structural MRI (T1WI and T2-FLair). Support Vector Machine (SVM) classifiers were developed using MRI radiomics data from both monomodal and multimodal radiomics models. The clinical-radiomics model was constructed by integrating clinical variables, including UPDRS, Hoehn-Yahr stage, age, sex, and MMSE scores. Receiver operating characteristic (ROC) curves were generated to evaluate the performance of the models. Decision curve analysis (DCA) was performed to access the clinical usefulness of the models. Results: In the training set, the T2-FLair and T1WI radiomics model achieved an AUC of 0.896 (95% CI, 0.812-0.900) and 0.899 (95% CI, 0.818-0.908), respectively. The double-sequence radiomics model demonstrated superior diagnostic performance, with an AUC of 0.965 (95% CI, 0.885-0.978) in the training set and an AUC of 0.852 (95% CI, 0.748-0.910) in the test set. The integrated clinical-radiomics model showed enhanced diagnostic accuracy, with AUC = 0.983 (95% CI, 0.897-0.996) in the training set and AUC = 0.837 (95% CI, 0.786-0.902) in the test set. Rad-scores derived from the radiomics model were significantly correlated with diagnostic outcomes ( Conclusion: The integrated clinical-radiomics model offered superior diagnostic performance compared to models based relying solely on imaging or clinical data, underscoring its potential as a non-invasive and effective tool in routine clinical practice for the early diagnosis of PD.

Indexed as

clinical-radiomics modelmachine learningMRI radiomicsParkinson’s diseaseT1-weighted imagingT2-FLair

Identifiers

PMID39957801
PMCPMC11825468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.